A carregar...

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors

In the past decade, recombinant vectors based on a non-pathogenic parvovirus, the adeno-associated virus (AAV), have taken center stage as a gene delivery vehicle for the potential gene therapy for a number of human diseases. To date, the safety of AAV vectors in 176 phase I, II, and III clinical tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Methods Clin Dev
Main Authors: Büning, Hildegard, Srivastava, Arun
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378346/
https://ncbi.nlm.nih.gov/pubmed/30815511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.01.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!